ACTA ENDOCRINOLOGICA-BUCHAREST, cilt.15, sa.4, ss.430-435, 2019 (SCI-Expanded, Scopus)
Objectives. Metabolic syndrome (MetS) is a cluster of metabolic abnormalities that is linked with increased circulating markers of oxidative stress and low-grade inflammation. The link between inflammation and MetS is not yet fully understood. We aim to evaluate the relationship between the levels of pro and anti-inflammatory markers such as apolipoprotein A1 (Apo-A1), apolipoprotein B (Apo-B), interleukin (IL) 6, tumor necrosis factor alpha (TNF-alpha), fibrinogen and complement component 3 (C3) and adiponectin and MetS/MetS components.